generic glp-1 receptor agonists glp-1_analogs [TUSOM Evolution of GLP‐1 Receptor Agonists

2004Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar

Following a single oral 100 mg dose to healthy volunteers, mean plasma AUC of sitagliptin was 8.52 Mhr, Cmax was 950 nM, and apparent terminal half-life (t1/2) was 12.4 hours

However, there are examples of drugs being withdrawn from the market as more long-term data comes to light

This would help answer the question of whether previously reported negative outcomes in other trials were a drug-specific retinal toxicity of the GLP-1/GIP receptor agonists vs

While the benefits are undeniable, the blockbuster growth and use of GLP-1 drugs has also highlighted potential side effects